Randomised, Double-Blind, Placebo-Controlled Trial of IVabradine in Patients With Acute Coronary Syndrome: Effects of the If Current Inhibitor Ivabradine or rEduction of Inflammation maRkers in Patients With Acute Coronary Syndrome.

Trial Profile

Randomised, Double-Blind, Placebo-Controlled Trial of IVabradine in Patients With Acute Coronary Syndrome: Effects of the If Current Inhibitor Ivabradine or rEduction of Inflammation maRkers in Patients With Acute Coronary Syndrome.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Acronyms Riviera
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 05 Apr 2011 Lead trial investigator (Alberto Dominguez Rodriguez) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top